
検索結果 15 件
| フルテキストURL | fulltext.pdf |
|---|---|
| 著者 | Nakamoto, Shogo| Shien, Tadahiko| Iwamoto, Takayuki| Kubo, Shinichiro| Yamamoto, Mari| Yamashita, Tetsumasa| Kuwahara, Chihiro| Ikeda, Masahiko| |
| 発行日 | 2024-04-30 |
| 出版物タイトル | Scientific Reports |
| 巻 | 14巻 |
| 号 | 1号 |
| 出版者 | Nature Portfolio |
| 開始ページ | 9869 |
| ISSN | 2045-2322 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 著作権者 | © The Author(s) 2024 |
| 論文のバージョン | publisher |
| PubMed ID | 38684839 |
| DOI | 10.1038/s41598-024-60101-x |
| Web of Science KeyUT | 001211286800006 |
| 関連URL | isVersionOf https://doi.org/10.1038/s41598-024-60101-x |
| フルテキストURL | fulltext.pdf |
|---|---|
| 著者 | Sasada, Shinsuke| Kondo, Naoto| Hashimoto, Hiroya| Takahashi, Yuko| Terata, Kaori| Kida, Kumiko| Sagara, Yasuaki| Ueno, Takayuki| Anan, Keisei| Suto, Akihiko| Kanbayashi, Chizuko| Takahashi, Mina| Nakamura, Rikiya| Ishiba, Toshiyuki| Tsuneizumi, Michiko| Nishimura, Seiichiro| Naito, Yoichi| Hara, Fumikata| Shien, Tadahiko| Iwata, Hiroji| |
| キーワード | Breast cancer T1a/b Endocrine therapy Estrogen receptor Prognosis |
| 備考 | The version of record of this article, first published in Breast Cancer Research and Treatment, is available online at Publisher’s website: http://dx.doi.org/10.1007/s10549-023-07097-6| |
| 発行日 | 2023-09-09 |
| 出版物タイトル | Breast Cancer Research and Treatment |
| 巻 | 202巻 |
| 号 | 3号 |
| 出版者 | Springer Science and Business Media LLC |
| 開始ページ | 473 |
| 終了ページ | 483 |
| ISSN | 0167-6806 |
| NCID | AA10623184 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 著作権者 | © The Author(s) 2023 |
| 論文のバージョン | publisher |
| PubMed ID | 37688665 |
| DOI | 10.1007/s10549-023-07097-6 |
| Web of Science KeyUT | 001065105700004 |
| 関連URL | isVersionOf https://doi.org/10.1007/s10549-023-07097-6 |
| JaLCDOI | 10.18926/AMO/63403 |
|---|---|
| フルテキストURL | 76_2_105.pdf |
| 著者 | Takaoka, Megumi| Ohsumi, Shozo| Ikejiri, Haruka| Shidahara, Tomohiro| Miyoshi, Yuichiro| Takahashi, Mina| Takashima, Seiki| Aogi, Kenjiro| |
| 抄録 | Cases of breast cancer metastasis after achieving a pathological complete response (pCR) with neoadjuvant chemotherapy (NAC) are sometimes encountered in clinical practice. We investigated the prognostic factors for pCR in patients with breast cancer after NAC. This retrospective cohort study included patients with localized breast cancer who underwent NAC followed by surgery between 2004 and 2020 and achieved a pCR. The associations between clinical factors and distant metastasis-free survival rate were statistically analyzed. We analyzed data for 127 patients. Twelve patients (9.4%) had distant metastases, and seven (5.5%) died. For estrogen receptor (ER)-positive patients, the distant metastasis-free survival rate was 94.6% for both 5 and 8 years. In contrast, ER-negative patients had a distant metastasis-free survival rate of 87.6% and 85.4% for 5 and 8 years (p=0.094), respectively. In cT0-2 patients, the distant metastasis-free survival rate was 92.4% for 5 years and 90.5% for 8 years, whereas in cT3-4 patients, the distant metastasis-free survival rate was 83.5% for 5 years and 83.5% for 8 years (p=0.301). This study suggested that patients with ER-negative, pre-NAC cT3 or T4 breast cancer who had achieved a pCR after NAC tended to have a worse prognosis. |
| キーワード | breast carcinoma neoadjuvant therapy prognosis |
| Amo Type | Original Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2022-04 |
| 巻 | 76巻 |
| 号 | 2号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 105 |
| 終了ページ | 111 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 著作権者 | Copyright Ⓒ 2022 by Okayama University Medical School |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 35503437 |
| Web of Science KeyUT | 000792374900001 |
| 著者 | Iwamoto, Takayuki| Hara, Fumikata| Uemura, Yukari| Mukai, Hirofumi| Watanabe, Toru| Ohashi, Yasuo| |
|---|---|
| キーワード | Chemotherapy-induced amenorrhea Taxane Taxane Breast cancer Guarantee-time bias Premenopause |
| 発行日 | 2020-05-28 |
| 出版物タイトル | Breast Cancer Research and Treatment |
| 巻 | 182巻 |
| 号 | 2号 |
| 出版者 | Springer |
| 開始ページ | 325 |
| 終了ページ | 332 |
| ISSN | 0167-6806 |
| NCID | AA10623184 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 論文のバージョン | author |
| PubMed ID | 32462261 |
| DOI | 10.1007/s10549-020-05692-5 |
| Web of Science KeyUT | 000539434600002 |
| 関連URL | isVersionOf https://doi.org/10.1007/s10549-020-05692-5 |
| フルテキストURL | fulltext.pdf |
|---|---|
| 著者 | Iwamoto, Takayuki| Fujisawa, Tomomi| Shien, Tadahiko| Araki, Kazuhiro| Sakamaki, Kentaro| Sangai, Takafumi| Kikawa, Yuichiro| Takao, Shintaro| Nishimura, Reiki| Takahashi, Masato| Aihara, Tomohiko| Mukai, Hirofumi| aira, Naruto| |
| キーワード | Metastatic breast cancer Endocrine therapies Estrogen receptor-positive HER2-negative Resistance |
| 発行日 | 2020-05-11 |
| 出版物タイトル | Breast Cancer |
| 巻 | 27巻 |
| 号 | 5号 |
| 出版者 | Springer |
| 開始ページ | 973 |
| 終了ページ | 981 |
| ISSN | 13406868 |
| NCID | AA1103354X |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 論文のバージョン | author |
| PubMed ID | 32394413 |
| DOI | 10.1007/s12282-020-01095-y |
| Web of Science KeyUT | 000531780600002 |
| 関連URL | isVersionOf https://doi.org/10.1007/s12282-020-01095-y |
| フルテキストURL | OL17_2_2177.pdf |
|---|---|
| 著者 | Miyoshi, Yuichiro| Shien, Tadahiko| Ogiya, Akiko| Ishida, Naoko| Yamazaki, Kieko| Horii, Rie| Horimoto, Yoshiya| Masuda, Norikazu| Yasojima, Hiroyuki| Inao, Touko| Osako, Tomofumi| Takahashi, Masato| Tomioka, Nobumoto| Wanifuchi‑Endo, Yumi| Hosoda, Mitsuchika| Doihara, Hiroyoshi| Yamashita, Hiroko| |
| キーワード | breast cancer estrogen receptor positive human epidermal growth factor receptor type 2 negative prognosis tumor infiltrating lymphocytes |
| 発行日 | 2018-12-19 |
| 出版物タイトル | Oncology Letters |
| 巻 | 17巻 |
| 号 | 2号 |
| 出版者 | Spandidos Publications |
| 開始ページ | 2177 |
| 終了ページ | 2186 |
| ISSN | 1792-1074 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 論文のバージョン | publisher |
| PubMed ID | 30675282 |
| DOI | 10.3892/ol.2018.9853 |
| Web of Science KeyUT | 000459551800096 |
| 関連URL | isVersionOf https://doi.org/10.3892/ol.2018.9853 |
| フルテキストURL | K0005596_other1.pdf |
|---|---|
| 著者 | Thar Htet San| Fujisawa, Masayoshi| Fushimi, Soichiro| Soe, Lamin| Ngu Wah Min| Yoshimura, Teizo| Ohara, Toshiaki| Myint Myint Yee| Oda, Shinsuke| Matsukawa , Akihiro| |
| キーワード | Breast cancer molecular subtypes Ki-67 expression Myanmar |
| 備考 | 学位審査副論文| |
| 発行日 | 2017-06-25 |
| 出版物タイトル | Asian Pacific journal of cancer prevention |
| 巻 | 18巻 |
| 号 | 6号 |
| 出版者 | Asian Pacific Organization for Cancer Prevention |
| 開始ページ | 1617 |
| 終了ページ | 1621 |
| ISSN | 1513-7368 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| OAI-PMH Set | 岡山大学 |
| 著作権者 | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja |
| 論文のバージョン | publisher |
| PubMed ID | 28670879 |
| DOI | 10.22034/APJCP.2017.18.6.1617 |
| 関連URL | isVersionOf https://doi.org/10.22034/APJCP.2017.18.6.1617 isPartOf http://ousar.lib.okayama-u.ac.jp/55521 |
| フルテキストURL | K0005471_abstract_review.pdf K0005471_summary.pdf K0005471_fulltext.pdf |
|---|---|
| 著者 | 三好 雄一郎| |
| 発行日 | 2017-03-24 |
| 資料タイプ | 学位論文 |
| 学位授与番号 | 甲第5471号 |
| 学位授与年月日 | 2017-03-24 |
| 学位・専攻分野 | 博士(医学) |
| 授与大学 | 岡山大学 |
| 言語 | 英語 |
| JaLCDOI | 10.18926/AMO/53907 |
|---|---|
| フルテキストURL | 69_6_333.pdf |
| 著者 | Ito, Maiko| Shien, Tadahiko| Kaji, Mitsumasa| Mizoo, Taeko| Iwamoto, Takayuki| Nogami, Tomohiro| Motoki, Takayuki| Taira, Naruto| Doihara, Hiroyoshi| Miyoshi, Shinichiro| |
| 抄録 | We evaluated the usefulness of preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) examinations to predict the pathological features in primary breast cancer. In particular, we evaluated the correlation between the maximum standardized uptake values (SUVmax) obtained by 18F-FDG PET/CT and the Ki67 expression in estrogen receptor (ER)-positive invasive ductal carcinoma (IDC). Primary IDC patients operated between March 2009 and July 2013 at Okayama University Hospital were enrolled. We evaluated the correlations between the SUVmax and age, postoperative pT, histological grade, lymph vascular invasion, status of hormone receptor, human epidermal growth factor receptor 2 (HER2), Ki67 expression and node status. The Ki67 expression was classified as high (>14%) versus low (<14%). We enrolled 138 patients with IDC. Their median SUVmax was 3.85 (range:0-52.57). In a univariate analysis, the SUVmax was significantly related to age, pT, histological grade, lymphovascular invasion, hormone receptor status, HER2 status, node status and Ki67. In the 113 patients with ER-positive IDC, there was a significant correlation between Ki67 and SUVmax (p=0.0030). The preoperative 18F-FDG PET/CT results of IDC patients had significant relationships with pathological status parameters. The determination of the preoperative SUVmax might help classify Luminal A and Luminal B patients among luminal-type breast cancer patients. |
| キーワード | breast cancer invasive ductal carcinoma 18F-fluorodeoxyglucose positron emission tomography/computed tomography maximum standardized uptake values clinicopathological features |
| Amo Type | Original Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2015-12 |
| 巻 | 69巻 |
| 号 | 6号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 333 |
| 終了ページ | 338 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 著作権者 | CopyrightⒸ 2015 by Okayama University Medical School |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 26690243 |
| Web of Science KeyUT | 000368434500002 |
| 著者 | Itoh, Mitsuya| Iwamoto, Takayuki| Matsuoka, Junji| Nogami, Tomohiro| Motoki, Takayuki| Shien, Tadahiko| Taira, Naruto| Niikura, Naoki| Hayashi, Naoki| Ohtani, Shoichiro| Higaki, Kenji| Fujiwara, Toshiyoshi| Doihara, Hiroyoshi| Symmans, W. Fraser| Pusztai, Lajos| |
|---|---|
| 発行日 | 2014-01 |
| 出版物タイトル | Breast Cancer Research and Treatment |
| 巻 | 143巻 |
| 号 | 2号 |
| 資料タイプ | 学術雑誌論文 |
| JaLCDOI | 10.18926/AMO/50409 |
|---|---|
| フルテキストURL | 67_3_165.pdf |
| 著者 | Shien, Tadahiko| Kinoshita, Takayuki| Seki, Kunihiko| Yoshida, Miwa| Hojo, Takashi| Shimizu, Chikako| Taira, Naruto| Doihara, Hiroyoshi| Akashi-Tanaka, Sadako| Tsuda, Hitoshi| Fujiwara, Yasuhiro| |
| 抄録 | While clinical and pathologic responses are important prognostic parameters, biological markers from core needle biopsy (CNB) are needed to predict neoadjuvant chemotherapy (NAC) response, to individualize treatment, and to achieve maximal efficacy. We retrospectively evaluated the cases of 183 patients with primary breast cancer who underwent surgery after NAC (anthracycline and taxane) at the National Cancer Center Hospital (NCCH). We analyzed EGFR, HER2, and p53 expression and common clinicopathological features from the CNB and surgical specimens of these patients. These biological markers were compared between sensitive patients (pathological complete response;pCR) and insensitive patients (clinical no change;cNC and clinical progressinve disease;cPD). In a comparison between the 9 (5%) sensitive patients and 30 (16%) insensitive patients, overexpression of p53 but not overexpression of either HER2 or EGFR was associated with a good response to NAC. p53 (p=0.045) and histological grade 3 (p=0.011) were important and significant predictors of the response to NAC. The correspondence rates for histological type, histological grade 3, ER, PgR, HER2, p53, and EGFR in insensitive patients between CNB and surgical specimens were 70%, 73%, 67%, 70%, 80%, 93%, and 73%. The pathologic response was significantly associated with p53 expression and histological grade 3. The correspondence rate of p53 expression between CNB and surgical specimens was higher than that of other factors. We conclude that the level of p53 expression in the CNB was an effective and reliable predictor of treatment response to NAC. |
| キーワード | breast cancer neoadjuvant chemotherapy predictors |
| Amo Type | Original Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2013-06 |
| 巻 | 67巻 |
| 号 | 3号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 165 |
| 終了ページ | 170 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 著作権者 | CopyrightⒸ 2013 by Okayama University Medical School |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 23804139 |
| Web of Science KeyUT | Pretreatment Specimen Predicts |
| 著者 | 木浦 勝行| 谷本 光音| |
|---|---|
| 発行日 | 2013-04-01 |
| 出版物タイトル | 岡山医学会雑誌 |
| 巻 | 125巻 |
| 号 | 1号 |
| 資料タイプ | 学術雑誌論文 |
| 著者 | Nogami, Tomohiro| Shien, Tadahiko| Tanaka, Takehiro| Nishiyama, Keiko| Mizoo, Taeko| Iwamto, Takayuki| Ikeda, Hirokuni| Taira, Naruto| Doihara, Hiroyoshi| Miyoshi, Shinichiro| |
|---|---|
| 発行日 | 2012-03-10 |
| 出版物タイトル | Breast Cancer |
| 資料タイプ | 学術雑誌論文 |
| 著者 | 万倉 三正| 野田 泰子| 森 昭胤| |
|---|---|
| 発行日 | 2012-04-01 |
| 出版物タイトル | 岡山医学会雑誌 |
| 巻 | 124巻 |
| 号 | 1号 |
| 資料タイプ | 学術雑誌論文 |
| 著者 | 土井原 博義| 平 成人| |
|---|---|
| 発行日 | 2008-01-04 |
| 出版物タイトル | 岡山医学会雑誌 |
| 巻 | 119巻 |
| 号 | 3号 |
| 資料タイプ | 学術雑誌論文 |